RHYTHM PHARMACEUTICALS, INC. (RYTM) FY2026 Q2 Balance Sheet

RHYTHM PHARMACEUTICALS, INC. (RYTM) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

437,266,000 US dollars

Current assets

426,563,000 US dollars

Non-current assets

10,703,000 US dollars

Liabilities

219,965,000 US dollars

Current liabilities

123,587,000 US dollars

Non-current liabilities

96,378,000 US dollars

Equity

102,983,000 US dollars

Series A convertible preferred stock, $0.001 par value: 150,000 shares authorized; 132,500 and 132500 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively. Liquidation preference of $132,500 and $132,500 as of March 31, 2026, and December 31, 2025, respectively.

114,318,000 US dollars

Short-term investments

265,283,000 US dollars

Cash and cash equivalents

65,614,000 US dollars

Accounts receivable, net

40,408,000 US dollars

Inventory

30,517,000 US dollars

Prepaid expenses and other current assets

24,741,000 US dollars

Intangible assets, net

4,892,000 US dollars

Right-of-use asset

2,817,000 US dollars

Other long-term assets

2,288,000 US dollars

Restricted cash

603,000 US dollars

Property and equipment, net

103,000 US dollars

Accrued expenses and other current liabilities

94,016,000 US dollars

Accounts payable

16,165,000 US dollars

Deferred royalty obligation, current

12,703,000 US dollars

Lease liability

703,000 US dollars

Deferred revenue

0 US dollars

Deferred royalty obligation

93,399,000 US dollars

Lease liability, non-current

2,979,000 US dollars

Additional paid-in capital

1,560,640,000 US dollars

Common stock, $0.001 par value: 120,000,000 shares authorized; 68,816,868 and 67,205,321 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively

69,000 US dollars

Preferred stock, $0.001 par value: 9,850,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025

0 US dollars

Accumulated deficit

negative 1,456,814,000 US dollars

Accumulated other comprehensive loss

negative 912,000 US dollars

Gross equity (calculated)

1,560,709,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus temporary equity plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.